| Previous Close | 14.01 |
| Open | 14.04 |
| Bid | 13.90 x 2200 |
| Ask | 14.20 x 1000 |
| Day's Range | 13.95 - 14.38 |
| 52 Week Range | 11.55 - 27.33 |
| Volume | 2,145,631 |
| Avg. Volume | 3,338,977 |
| Market Cap | 2.709B |
| Beta (3Y Monthly) | 1.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.29 |
| Earnings Date | Feb 1, 2017 - Feb 6, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.25 |
NEW YORK, Feb. 18, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
NEW YORK, Feb. 17, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
NEW YORK, Feb. 17, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of NVIDIA Corporation, DXC.
NEW YORK, Feb. 17, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc. (IMMU), if they purchased the Company’s shares between the expanded period of February 8, 2018 and January 18, 2019, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey. Immunomedics investors should visit us at https://www.claimsfiler.com/cases/view-immunomedics-inc-securities-litigation-1 or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
The law firm of Kessler Topaz Meltzer & Check, LLP alerts Immunomedics, Inc. (IMMU) (“Immunomedics”) investors that two securities fraud class action lawsuits have been filed in the United States District Court for the District of New Jersey (the “District of New Jersey”) against Immunomedics on behalf of purchasers of Immunomedics common stock between February 8, 2018 and January 18, 2019, inclusive (the “Class Period”).
NEW YORK, Feb. 15, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Immunomedics, Inc. (NASDAQ: IMMU) from February 8, 2018.
NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Immunomedics, Inc. ("Immunomedics" or the ...
NEW YORK, Feb. 15, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Immunomedics, Inc. ("Immunomedics" or the ...
NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can ...
NEW YORK, Feb. 15, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
RADNOR, Pa., Feb. 14, 2019 -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics”) investors that two securities.
Pomerantz LLP announces that a class action lawsuit has been filed against Immunomedics, Inc. (“Immunomedics” or the “Company”) (IMMU) and certain of its officers and directors. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Immunomedics, Inc. (NASDAQ: IMMU) ...
NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Immunomedics, Inc. (''Immunomedics'' or the ''Company'') (IMMU) of the February 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Immunomedics stock oroptions between August 23, 2018 and December 20, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/IMMU. You can also contact us by calling Richard Gonnello toll free at877-247-4292 or at 212-983-9330 or by sending an e-mail torgonnello@faruqilaw.com.
NEW YORK, NY / ACCESSWIRE / February 14, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review ...
NEW YORK, Feb. 13, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
NEW YORK, Feb. 13, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..